register

News & Trends - Pharmaceuticals

TGA publishes vaccine safety monitoring plan

Health Industry Hub | February 19, 2021 |
[Total: 1    Average: 4/5]

Pharma News: The Therapeutic Goods Administration (TGA) has published a five-point plan detailing the enhanced measures it will put in place to ensure the timely identification and mitigation of safety issues during the roll out of COVID-19 vaccines.

The publication of the plan follows the recent provisional approvals of Pfizer/BioNTech and AstraZeneca/University of Oxford vaccines, and the start of a national vaccination strategy that is initially targeting around 700,000 people, including quarantine and border workers and the residents and staff at aged and disability care facilities.

The agency aims to “strengthen the existing vaccine vigilance system for early detection and investigation of suspected side effects,” thereby enabling it to manage emerging safety issues and maintain public confidence.

Specifically, TGA is putting into place an enhanced adverse event reporting process to ensure the timely collection and management of reports; forms will be particularised for each vaccine and will be sharable between its staff and regional officials.

The agency also seeks to enhance safety signal detection and investigation by ensuring it has the capacity to perform timely reviews of adverse event reports and the ability to collaborate in real time with AusVaxSafety, the national vaccine safety system. Upon identification of a safety concern, TGA will “use legislative provisions available to achieve effective and timely regulatory action” that may help to address or reduce the emerging risk.

TGA also will ensure information quickly reaches consumers, health professionals and sponsors and will proactively monitor media reports to proactively identify public concerns about vaccine safety.

To achieve those goals, TGA plans to collaborate with state and federal governments and experts in Australia on the consolidation of “timely information sharing, communication and collaboration with national stakeholders on COVID-19 vaccine safety,” as well as with officials and regulators overseas.

See details of TGA’s Monitoring Plan.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Digital & Innovation

Healthcare Technology Digital Innovations - Shifts in Pharma’s digital health landscape - Deep dive with Dr Ramin Rafiei

Shifts in Pharma’s digital health landscape – Deep dive with Dr Ramin Rafiei

Health Industry Hub | March 1, 2021 |

In this Health Industry Hub interview, Dr Ramin Rafiei takes us on a deep dive into the current digital health […]

More


News & Trends - Pharmaceuticals

Pharma News - Boehringer Ingelheim reduces carbon footprint with launch of reusable inhaler

Boehringer Ingelheim reduces carbon footprint with launch of reusable inhaler

Health Industry Hub | March 1, 2021 |

Pharma News: Boehringer Ingelheim has reinforced its commitment to increased sustainability within the healthcare sector, launching a more eco-friendly version […]

More


Medical

$1.3 billion manufacturing funding opens for medicines and medical devices

Health Industry Hub | March 1, 2021 |

Medical News: The Morrison Government is backing Australia’s medical products manufacturers to grow and create new jobs, with applications for […]

More


News & Trends - Medical Technology

MedTech News - $100 million funding for major advances in medical technology

$100 million funding for major advances in medical technology

Health Industry Hub | March 1, 2021 |

MedTech News: $100 million is being invested into the development of new medical technologies to improve diagnosis and treatment of […]

More